A Phase 1 Study of AZD9833 in Japanese Women With ER Positive, HER2 Negative Advanced Breast Cancer

Clinical trial NCT04541433 · COMPLETED

Trial details

NCT number: NCT04541433
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

ER+ HER2- Advanced Breast Cancer

Start date: 2020-09-29
Primary completion: 2022-07-29
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.